CN Stock MarketDetailed Quotes
300639 Guangdong Hybribio Biotech
- 5.80
- -0.14-2.36%
Market Closed May 23 15:00 CST
3.75BMarket Cap61.70P/E (TTM)
5.97High5.80Low65.85KlotVolume5.95Open5.94Pre Close38.57MTurnover1.04%Turnover Ratio26.73P/E (Static)646.50MShares11.1352wk High0.78P/B3.68BFloat Cap5.5952wk Low7.13Limit Up635.16MShs Float20.96Historical High4.75Limit Down2.86%Amplitude2.50Historical Low0.07Dividend TTM5.86Avg Price41.83KlotAsk1.12%Div YieldTTM100Lot Size23.14KlotBid
Guangdong Hybribio Biotech Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -57.61%263.05M | -47.70%2.02B | -49.91%1.33B | -43.00%948.95M | -9.24%620.54M | 75.07%3.85B | 80.74%2.65B | 119.37%1.66B | 93.46%683.69M | 88.99%2.2B |
| Refunds of taxes and levies | -96.80%191.87K | -93.71%57.15K | 28.44%12.66M | -5.45%6.33M | 12,029.30%5.99M | 44.20%908.12K | 1,163.08%9.86M | 1,868.47%6.7M | -80.87%49.37K | -0.63%629.78K |
| Cash received relating to other operating activities | -51.58%3.59M | 183.61%66.05M | -40.33%28.76M | 139.71%17.75M | 39.49%7.4M | -7.85%23.29M | 243.05%48.2M | 57.87%7.41M | 49.15%5.31M | -11.61%25.27M |
| Cash inflows from operating activities | -57.91%266.83M | -46.32%2.08B | -49.46%1.37B | -42.05%973.03M | -8.00%633.93M | 74.12%3.88B | 82.85%2.71B | 119.77%1.68B | 92.89%689.04M | 86.53%2.23B |
| Goods services cash paid | -66.36%54.29M | -54.99%490.1M | -56.46%405.49M | -52.68%310.62M | -38.39%161.37M | 47.30%1.09B | 54.66%931.25M | 79.54%656.36M | 27.94%261.93M | 162.94%739.25M |
| Staff behalf paid | -37.49%116.79M | -20.90%511.85M | -12.62%379.71M | 7.89%285.09M | 39.15%186.83M | 103.10%647.07M | 93.65%434.54M | 79.73%264.25M | 71.51%134.27M | 75.85%318.6M |
| All taxes paid | -1.04%86.74M | 16.85%364.73M | -36.40%147.52M | -16.71%132.16M | 62.81%87.66M | 81.65%312.13M | 96.69%231.94M | 143.76%158.67M | 49.04%53.84M | 80.26%171.83M |
| Cash paid relating to other operating activities | -43.32%73.06M | -24.13%395.92M | -39.15%248.22M | -24.76%173.07M | 7.65%128.89M | 42.26%521.87M | 45.46%407.93M | 28.60%230.03M | 36.09%119.73M | 12.73%366.83M |
| Cash outflows from operating activities | -41.41%330.88M | -31.42%1.76B | -41.12%1.18B | -31.19%900.95M | -0.88%564.76M | 60.97%2.57B | 63.75%2.01B | 73.06%1.31B | 39.95%569.76M | 80.80%1.6B |
| Net cash flows from operating activities | -192.59%-64.05M | -75.59%319.6M | -73.11%190.15M | -80.50%72.09M | -42.00%69.18M | 107.37%1.31B | 173.24%707.11M | 4,883.86%369.68M | 339.07%119.28M | 102.81%631.34M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 48.40%300M | -58.92%1.09B | -56.63%854.92M | -47.45%728.5M | -66.96%202.15M | -4.21%2.66B | -8.23%1.97B | -11.72%1.39B | -58.68%611.8M | 122.91%2.77B |
| Cash received from returns on investments | 47.48%788.29K | --7.64M | ---- | --0 | -81.66%534.5K | ---- | -23.23%14.44M | 16.10%13.43M | -61.54%2.91M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -93.75%2.34K | 29.26%17.74M | -98.99%67.25K | -99.14%56.04K | -16.74%37.47K | 116.54%13.72M | 894.71%6.67M | 1,135.14%6.52M | -83.53%45K | -8.46%6.34M |
| Cash inflows from investing activities | 48.38%300.79M | -58.18%1.12B | -57.09%854.99M | -48.19%728.55M | -67.02%202.72M | -3.94%2.67B | -8.08%1.99B | -11.14%1.41B | -58.70%614.76M | 122.18%2.78B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -70.98%43.89M | -47.53%385.32M | -29.70%325.55M | -12.55%252.33M | -10.97%151.22M | 14.55%734.37M | 20.34%463.08M | 25.27%288.53M | 68.23%169.86M | 123.28%641.07M |
| Cash paid to acquire investments | 46.76%285M | -59.98%1.02B | -60.86%735.2M | -56.13%596.95M | -60.97%194.2M | -3.83%2.54B | -5.47%1.88B | -6.44%1.36B | -63.01%497.6M | 22.69%2.64B |
| Cash outflows from investing activities | -4.79%328.89M | -57.19%1.4B | -54.70%1.06B | -48.50%849.28M | -48.25%345.42M | -0.24%3.28B | -1.28%2.34B | -2.10%1.65B | -53.85%667.46M | 34.52%3.28B |
| Net cash flows from investing activities | 80.31%-28.1M | 52.84%-285.21M | 41.08%-205.77M | 50.29%-120.73M | -170.77%-142.7M | -20.14%-604.75M | -70.71%-349.24M | -138.11%-242.84M | -224.62%-52.7M | 57.70%-503.35M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | -85.77%10M | -82.14%10M | 899.90%10M | ---- | -93.23%70.25M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | 899.90%10M | 899.90%10M | ---- | ---- |
| Cash from borrowing | ---- | -60.23%79.86M | -56.77%71.62M | -59.46%61.62M | -19.13%1.62M | -19.14%200.79M | -32.78%165.68M | -15.56%152M | -97.94%2M | 205.56%248.33M |
| Cash received relating to other financing activities | ---- | --20.41K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | -62.11%79.88M | -59.23%71.62M | -61.96%61.62M | -19.13%1.62M | -33.84%210.79M | -42.30%175.68M | -11.48%162M | -97.94%2M | -71.54%318.58M |
| Borrowing repayment | --1.62M | -41.72%147.88M | -65.75%83.68M | -60.73%50M | ---- | 47.29%253.73M | 224.60%244.33M | 69.16%127.33M | 32.85%100M | 2,771.20%172.27M |
| Dividend interest payment | 287.07%2.96M | 40.40%160.46M | 47.16%154.36M | 47.56%153.52M | -24.54%765.89K | 50.20%114.29M | 68.20%104.89M | 72.13%104.04M | 56.22%1.01M | 73.86%76.09M |
| Cash payments relating to other financing activities | 416.10%30.55M | 6.05%65.94M | 4,017.59%56.1M | 6,662.94%54.77M | 41,157.86%5.92M | 0.74%62.18M | -97.45%1.36M | -98.55%809.85K | -14.11%14.35K | 16.64%61.72M |
| Cash outflows from financing activities | 425.51%35.14M | -13.00%374.28M | -16.10%294.14M | 11.25%258.29M | -93.38%6.69M | 38.74%430.2M | 83.42%350.58M | 21.20%232.18M | 33.04%101.03M | 201.99%310.08M |
| Net cash flows from financing activities | -593.21%-35.14M | -34.18%-294.4M | -27.23%-222.52M | -180.24%-196.67M | 94.88%-5.07M | -2,681.82%-219.41M | -254.35%-174.9M | -718.50%-70.18M | -570.19%-99.03M | -99.16%8.5M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 118.88%2.59M | -92.93%947.86K | 104.44%1.82M | -194.57%-3.72M | -162.03%-13.74M | 344.70%13.4M | -6,455.09%-40.92M | 208.32%3.93M | -626.26%-5.24M | -25.48%-5.48M |
| Net increase in cash and cash equivalents | -35.06%-124.69M | -151.97%-259.07M | -266.37%-236.32M | -510.94%-249.03M | -144.95%-92.33M | 280.47%498.46M | -14.89%142.04M | 159.49%60.6M | -395.97%-37.69M | -1.95%131.01M |
| Add:Begin period cash and cash equivalents | -25.36%764.93M | 95.50%1.02B | 96.33%1.02B | 96.33%1.02B | 96.33%1.02B | 33.51%521.97M | 33.51%521.97M | 33.51%521.97M | 33.51%521.97M | 51.93%390.96M |
| End period cash equivalent | -31.34%640.24M | -25.39%761.37M | 18.74%788.45M | 33.16%775.75M | 92.54%932.45M | 95.50%1.02B | 19.03%664.02M | 101.52%582.57M | 19.96%484.28M | 33.51%521.97M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg